Qiu Z - Search Results

1

Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus ¹⁸F-FDG PET/CT for Detection of Bone Metastases.

Sun W, Li M, Gu Y, Sun Z, Qiu Z, Zhou Y. Sun W, et al. Among authors: qiu z. AJR Am J Roentgenol. 2020 Feb;214(2):446-454. doi: 10.2214/AJR.19.21656. Epub 2019 Dec 4. AJR Am J Roentgenol. 2020. PMID: 31799866

2

Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT.

Qiu ZL, Luo QY. Qiu ZL, et al. Clin Nucl Med. 2009 Mar;34(3):137-40. doi: 10.1097/RLU.0b013e31819675b6. Clin Nucl Med. 2009. PMID: 19352273

3

Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT.

Qiu ZL, Xu YH, Song HJ, Luo QY. Qiu ZL, et al. Head Neck. 2011 Feb;33(2):171-7. doi: 10.1002/hed.21416. Head Neck. 2011. PMID: 20848436

4

Brain metastases with exceptional features from papillary thyroid carcinoma: report of three cases.

Xu YH, Song HJ, Qiu ZL, Luo QY. Xu YH, et al. Hell J Nucl Med. 2011 Jan-Apr;14(1):56-9. Hell J Nucl Med. 2011. PMID: 21512667

5

Rare metastases of differentiated thyroid carcinoma: pictorial review.

Song HJ, Xue YL, Xu YH, Qiu ZL, Luo QY. Song HJ, et al. Endocr Relat Cancer. 2011 Aug 30;18(5):R165-74. doi: 10.1530/ERC-11-0068. Print 2011 Oct. Endocr Relat Cancer. 2011. PMID: 21632805 Review.

6

Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer.

Qiu ZL, Song HJ, Xu YH, Luo QY. Qiu ZL, et al. J Clin Endocrinol Metab. 2011 Oct;96(10):3078-86. doi: 10.1210/jc.2011-0093. Epub 2011 Jul 27. J Clin Endocrinol Metab. 2011. PMID: 21795449

7

Uncommon metastases from differentiated thyroid carcinoma.

Song HJ, Xue YL, Qiu ZL, Luo QY. Song HJ, et al. Hell J Nucl Med. 2012 Sep-Dec;15(3):233-40. doi: 10.1967/s002449910059. Epub 2012 Oct 25. Hell J Nucl Med. 2012. PMID: 23106056 Review.

8

Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.

Qiu ZL, Xue YL, Song HJ, Luo QY. Qiu ZL, et al. Nucl Med Commun. 2012 Dec;33(12):1232-42. doi: 10.1097/MNM.0b013e328358d9c0. Nucl Med Commun. 2012. PMID: 23111353

9

Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.

Xue YL, Qiu ZL, Song HJ, Luo QY. Xue YL, et al. Eur J Nucl Med Mol Imaging. 2013 May;40(5):768-78. doi: 10.1007/s00259-012-2310-x. Epub 2012 Dec 15. Eur J Nucl Med Mol Imaging. 2013. PMID: 23242250 Review.

10

Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.

Xu YH, Shen CT, Xue YL, Qiu ZL, Luo QY. Xu YH, et al. Hell J Nucl Med. 2013 Sep-Dec;16(3):199-203. Hell J Nucl Med. 2013. PMID: 24251307 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,214 results

Search Page

Filters